• Users Online: 425
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2014  |  Volume : 5  |  Issue : 3  |  Page : 111-114

Secondary plasma cell leukemia in a patient with light chain multiple myeloma in post-chemotherapy remission phase

Department of Internal Medicine, University Hospital Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo León, México, USA

Correspondence Address:
Dania Lizet Quintanilla-Flores
Department of Internal Medicine?, University Hospital Dr. José Eleuterio González, Av. Francisco I. Madero y Av. Gonzalitos, Col. Mitras Centro, Monterrey, Nuevo Leon, ZIP 64460, Mexico
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1658-5127.142000

Rights and Permissions

Plasma cell leukemia (PCL) is a rare presentation of multiple myeloma characterized by the presence of >20% plasma cells in peripheral blood, and an absolute plasma cell count >2 × 109 K/L. It is classified as primary and secondary with the latter representing a terminal event in 12% of patients. A case of a 78-year-old man who presented a secondary form of PCL during post-chemotherapy remission phase is discussed accompanied with a brief review.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded288    
    Comments [Add]    

Recommend this journal